0001104659-23-072402.txt : 20230616
0001104659-23-072402.hdr.sgml : 20230616
20230616190511
ACCESSION NUMBER: 0001104659-23-072402
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230614
FILED AS OF DATE: 20230616
DATE AS OF CHANGE: 20230616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LINDSTROM RICHARD L MD
CENTRAL INDEX KEY: 0001242177
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36554
FILM NUMBER: 231022830
MAIL ADDRESS:
STREET 1: 2811 WESTWOOD PL
CITY: WAYZATA
STATE: MN
ZIP: 55391
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OCULAR THERAPEUTIX, INC
CENTRAL INDEX KEY: 0001393434
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-895-3235
MAIL ADDRESS:
STREET 1: 24 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: I-THERAPEUTIX INC
DATE OF NAME CHANGE: 20070315
4
1
tm2318782-4_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-06-14
0
0001393434
OCULAR THERAPEUTIX, INC
OCUL
0001242177
LINDSTROM RICHARD L MD
C/O OCULAR THERAPEUTIX, INC.
24 CROSBY DRIVE
BEDFORD
MA
01730
1
0
0
0
0
Common Stock
2023-06-14
4
A
0
12000
0
A
120402
D
Stock Option (Right to Buy)
5.31
2023-06-14
4
A
0
36000
0
A
2033-06-13
Common Stock
36000
36000
D
On June 14, 2023, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
/s/ Donald Notman, Attorney-in-Fact for Richard L. Lindstrom, M.D.
2023-06-16